Page 1 of Clinical Trials for Biological fludarabine phosphate, 317 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy, and G-CSF or GM-CSF in Treating Patients With Metastatic Melanoma
Last Updated: May 7, 2010
Condition(s): Melanoma (Skin)
2
Completed
Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
Last Updated: November 22, 2011
Condition(s): Leukemia
3
Completed
Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma
Last Updated: May 11, 2012
Condition(s): Melanoma (Skin)
4
Active, not recruiting
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Last Updated: February 6, 2009
Condition(s): Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes
5
Completed
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia
Last Updated: May 10, 2011
Condition(s): Leukemia
6
Terminated
Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer
Last Updated: February 27, 2012
Condition(s): Breast Cancer; Colorectal Cancer; Gastric Cancer; Lung Cancer; Ovarian Cancer; Pancreatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
7
Active, not recruiting
FCR or BR in Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Last Updated: March 14, 2012
Condition(s): Leukemia
8
Completed
Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma
Last Updated: May 5, 2010
Condition(s): Melanoma (Skin)
9
Recruiting
Fludarabine, Cyclophosphamide, and Rituximab Followed by Rituximab or Observation in Treating Older Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia
Last Updated: December 13, 2009
Condition(s): Leukemia
10
Recruiting
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Last Updated: March 14, 2012
Condition(s): Myelodysplastic Syndrome; Hodgkin's Lymphoma; Non-Hodgkin's Disease; Acute Leukemia; Multiple Myeloma
11
Withdrawn
Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission
Last Updated: July 6, 2006
Condition(s): Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia
12
Completed
Denileukin Diftitox in Treating Patients With Fludarabine-Refractory B-Cell Chronic Lymphocytic Leukemia
Last Updated: February 6, 2009
Condition(s): Leukemia
13
Terminated
Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
Last Updated: January 24, 2008
Condition(s): Chronic Myeloproliferative Disorders; Leukemia; Myelodysplastic/Myeloproliferative Diseases
14
Active, not recruiting
Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's Lymphoma
Last Updated: May 24, 2012
Condition(s): Lymphoma
15
Terminated
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
Last Updated: August 11, 2011
Condition(s): Recurrent Grades 1-3 Follicular Lymphoma; Follicular Lymphoma
16
Active, not recruiting
Fludarabine and Thalidomide in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
Last Updated: October 20, 2011
Condition(s): Leukemia
17
Recruiting
Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia
Last Updated: November 30, 2007
Condition(s): Waldenström Macroglobulinemia; Lymphoplasmacytic Lymphoma; Splenic Marginal Zone Lymphoma
18
Recruiting
Induction, Consolidation and Intensification Therapy for Patients Younger Than 66 Years With Previously Untreated CD33 Positive Acute Myeloid Leukemia (AML)
Last Updated: January 25, 2010
Condition(s): Acute Myeloid Leukemia
19
Active, not recruiting
Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine
Last Updated: March 9, 2012
Condition(s): Chronic Lymphocytic Leukemia
20
Completed
Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
Last Updated: December 9, 2005
Condition(s): Follicular Lymphoma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Biological+fludarabine+phosphate

Page 1 of Clinical Trials for Biological fludarabine phosphate, 317 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About